Compositions and methods for treating hemoglobinopathies
US-2026061041-A1 · Mar 5, 2026 · US
This page is not indexed by search engines while we improve data quality.
Born David A patents
Born David A is listed as an inventor on 22 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Born David A |
| Total patents | 22 |
| First publication | May 6, 2021 |
| Latest publication | Mar 5, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Crispr enzymes, methods, systems and uses thereof
US-2024327813-A1 · Oct 3, 2024 · US
Compositions and methods for treating hemoglobinopathies
US-12016908-B2 · Jun 25, 2024 · US
Novel crispr enzymes, methods, systems and uses thereof
US-2024167008-A1 · May 23, 2024 · US
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
US-2024132867-A1 · Apr 25, 2024 · US
Compositions and methods for treating hemoglobinopathies
US-11752202-B2 · Sep 12, 2023 · US
Methods of editing a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease
US-2023140953-A1 · May 11, 2023 · US
Compositions and methods for treating hemoglobinopathies
US-2023128472-A1 · Apr 27, 2023 · US
Compositions and methods for treating alpha-1 antitrypsin deficiency
US-2023101597-A1 · Mar 30, 2023 · US
Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence
US-2023080198-A1 · Mar 16, 2023 · US
Recent patents
Latest publications not already listed above.
Compositions and methods for treating hemoglobinopathies
US-2022370575-A1 · Nov 24, 2022 · US
Compositions and methods for treating hemoglobinopathies
US-2022235347-A1 · Jul 28, 2022 · US
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
US-2022170027-A1 · Jun 2, 2022 · US
Compositions and methods for treating hemoglobinopathies
US-11344609-B2 · May 31, 2022 · US
Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequence
US-2022136012-A1 · May 5, 2022 · US
Compositions and methods for treating glycogen storage disease type 1a
US-2022127594-A1 · Apr 28, 2022 · US
Splice acceptor site disruption of a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease
US-2022098593-A1 · Mar 31, 2022 · US
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
US-11155803-B2 · Oct 26, 2021 · US
Compositions and methods for treating hemoglobinopathies
US-11142760-B2 · Oct 12, 2021 · US
Compositions and methods for treating hemoglobinopathies
US-2021261955-A1 · Aug 26, 2021 · US
Compositions and methods for treating hemoglobinopathies
US-2021252118-A1 · Aug 19, 2021 · US
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
US-2021130805-A1 · May 6, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Beam Therapeutics Inc | 22 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N9/22 | 22 |
| C12Y305/04004 | 22 |
| C12N9/78 | 22 |
| C12N2310/20 | 22 |
| C12N15/102 | 21 |